登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《CID，3月28日，Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-29

  • Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

    Juanjuan Zhao, Quan Yuan, Haiyan Wang, Wei Liu, Xuejiao Liao, Yingying Su, Xin Wang, Jing Yuan, Tingdong Li, Jinxiu Li ... Show more Author Notes

    Clinical Infectious Diseases, ciaa344, https://doi.org/10.1093/cid/ciaa344

    Published: 28 March 2020

    Abstract

    Background

    The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patient remains largely unknown, and the clinical values of antibody testing have not been fully demonstrated.

    Methods

    A total of 173 patients with SARS-CoV-2 infection were enrolled. Their serial plasma samples (n=535) collected during the hospitalization were tested for total antibodies (Ab), IgM and IgG against SARS-CoV-2. The dynamics of antibodies with the disease progress was analyzed.

  • 原文来源：https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa344/5812996?searchresult=1#
151浏览量
原文链接
相关报告

  • 《MedRixv，3月3日，Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-04
    • Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 Juanjuan Zhao Jr., Quan Yuan, Haiyan Wang, Wei Liu, Xuejiao Liao, Yingying Su, Xin Wang, Jing Yuan, Tingdong Li, Jinxiu Li, Shen Qian, Congming Hong, Fuxiang Wang, Yingxia Liu, Zhaoqin Wang, Qing He, Zhiyong Li, Bin He, Tianying Zhang, Shengxiang Ge, Lei Liu, Jun Zhang, Ningshao Xia, Zheng Zhang doi: https://doi.org/10.1101/2020.03.02.20030189 Abstract Summary Background The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patient remains largely unknown, and the clinical values of antibody testing have not been fully demonstrated. Methods A total of 173 patients with confirmed SARS-CoV-2 infection were enrolled. Their serial plasma samples (n = 535) collected during the hospitalization period were tested for total antibodies (Ab), IgM and IgG against SARS-CoV-2 using immunoassays. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    64浏览量
    原文链接

  • 《CID，3月28日，Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-29
    • Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients Fengting Yu, Liting Yan, Nan Wang, Siyuan Yang, Linghang Wang, Yunxia Tang, Guiju Gao, Sa Wang, Chengjie Ma, Ruming Xie ... Show more Author Notes Clinical Infectious Diseases, ciaa345, https://doi.org/10.1093/cid/ciaa345 Published: 28 March 2020 Abstract Background Coronavirus disease 2019 (COVID-19) has become a public health emergency. The widely used reverse transcription PCR (RT-PCR) method has limitations for clinical diagnosis and treatment. Methods A total of 323 samples from 76 COVID-19 confirmed patients were analyzed by droplet digital PCR (ddPCR) and RT-PCR based two target genes (ORF1ab and N). Nasal swabs, throat swabs, sputum, blood, and urine were collected. Clinical and imaging data were obtained for clinical staging.
    194浏览量
    原文链接